In This Section

Brain Microglia & Astrocytes in Health and Disease

Saturday April 04, 2020

2:00 pm - 4:00 pm

Room 15 B
Sponsored by the Division for Drug Discovery and Development (DDD)
Co-sponsored by the Division for Behavioral Pharmacology (BEH)
Co-sponsored by the Division for Neuropharmacology (NEU)

Chair :

Anindya Bhattacharya
Janssen R&D

There is a growing body of literature pointing to the role of glia and BBB cells in CNS health and disease. The symposium aims to highlight recent progress in microglial P2X7 and CSF1R biology and review recent data on astrocyte-neuron communication leading to modulation of synaptic plasticity. Finally, the importance of BBB cells in health and disease will be discussed briefly. The goal of the symposium is to highlight the growing importance of non-neuronal cells in CNS (patho)physiology, perhaps providing insight to novel biology leading to innovative therapies targeting microglia and astrocytes.

Microglial P2X7: An 'On-Demand' Modulator of Neuroinflammation
Anindya Bhattacharya - Janssen R&D

Microglia Facilitate Plaque Formation in Alzheimer's Disease
Kim Green - University of California, Irvine

Astrocyte-synapse Interactions in Aging and Neurodegeneration
Nicola Allen - Salk Institute

Astrocytes and Huntington’s Disease
Baljit Khakh - University of California, Los Angeles

Regulation of the Blood-Brain Barrier in Health and Disease
Richard Daneman - University of California, San Diego

Last Updated: November 8, 2019
Key Dates
March 6

Housing discounts end

March 13

Advance Registration Ends

April 3-4

GPCR Colloquium (separate ticket required)

April 4

ASPET Business Meeting and Awards Presentation

April 4-7

ASPET Annual Meeting at EB 2020

Thank you to our Annual Meeting partners:

University of Kentucky
Icahn School
University of Georgia
University of Minnesota
WSU Pharm-Pharm Sciences Unit
PR & P